4 – Alzheimers

There is currently nothing on the market that halts or even slows down the progression of Alzheimer’s in patients. In our second series report, we look at the disease’s ongoing research and drug trials.

Read more here:
Alzheimer’s Research Seeks Earlier Detection

Alzheimer’s sufferers will soon get unrestricted access to a drug to slow down the progression of the disease.

See the original post:
Alzheimer’s drug funding announced